These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37414962)

  • 1. Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Yan Z; Tong P; Xia Q; He K
    Cell Oncol (Dordr); 2023 Dec; 46(6):1595-1604. PubMed ID: 37414962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
    Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
    Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
    Yin Z; Dong C; Jiang K; Xu Z; Li R; Guo K; Shao S; Wang L
    J Hematol Oncol; 2019 Sep; 12(1):101. PubMed ID: 31547836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinoma.
    Chen S; Gao Y; Wang Y; Daemen T
    Int J Cancer; 2022 Sep; 151(5):809-824. PubMed ID: 35467769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells.
    Huang H; Tsui YM; Ng IO
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1105-1116. PubMed ID: 36736664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.
    Sas Z; Cendrowicz E; Weinhäuser I; Rygiel TP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
    Deng Z; Wang J; Xu B; Jin Z; Wu G; Zeng J; Peng M; Guo Y; Wen Z
    Biomed Res Int; 2019; 2019():2408348. PubMed ID: 31828095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.
    Chen C; Wang Z; Ding Y; Qin Y
    Front Immunol; 2023; 14():1133308. PubMed ID: 36845131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
    Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
    Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma.
    Wang T; Chen B; Meng T; Liu Z; Wu W
    Bioengineered; 2021 Dec; 12(1):1555-1575. PubMed ID: 33955820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
    Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
    Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma.
    Zhang X; Li N; Zhu Y; Wen W
    Cancer Med; 2022 Feb; 11(4):931-943. PubMed ID: 34981659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spatial distribution of immune cell subpopulations in hepatocellular carcinoma.
    Wang PC; Hu ZQ; Zhou SL; Yu SY; Mao L; Su S; Li J; Ren N; Huang XW
    Cancer Sci; 2022 Feb; 113(2):423-431. PubMed ID: 34779545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma.
    Wang X; Hassan W; Jabeen Q; Khan GJ; Iqbal F
    Cytokine; 2018 Mar; 103():150-159. PubMed ID: 29029799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression.
    Kotsari M; Dimopoulou V; Koskinas J; Armakolas A
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny.
    Sheng J; Zhang J; Wang L; Tano V; Tang J; Wang X; Wu J; Song J; Zhao Y; Rong J; Cheng F; Wang J; Shen Y; Wen L; He J; Zhang H; Li T; Zhang Q; Bai X; Lu Z; Liang T
    Gut; 2022 Jun; 71(6):1176-1191. PubMed ID: 34253573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.